Renalytix annual revenue
2020
2021
2022
2023
2024
2025
Renalytix Revenue Growth & History (RENX)
Renalytix reported $3.0M in revenue for fiscal 2025, an increase of 31.06% from the previous fiscal year.
View full Renalytix company overviewRenalytix annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $3.0M | $711,000 | +31.06% |
| 2024 | 2024-06-30 | $2.3M | $2.2M | +2189.00% |
| 2023 | 2023-06-30 | $100,000 | −$2.9M | −96.63% |
| 2022 | 2022-06-30 | $3.0M | $1.5M | +99.20% |
| 2021 | 2021-06-30 | $1.5M | $1.5M | — |
| 2020 | 2020-06-30 | $0 | — | — |
Renalytix quarterly revenue
Q3.21
Q1.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2025 | 2024-12-31 | $729,000 | $20,000 | +2.82% |
| Q1 2025 | 2024-09-30 | $522,000 | $63,000 | +13.73% |
| Q4 2024 | 2024-06-30 | $586,000 | $3.4M | +121.04% |
| Q3 2024 | 2024-03-31 | $535,000 | −$189,000 | −26.10% |
| Q2 2024 | 2023-12-31 | $709,000 | −$483,000 | −40.52% |
| Q1 2024 | 2023-09-30 | $459,000 | −$510,000 | −52.63% |
| Q4 2023 | 2023-06-30 | −$2.8M | — | — |
| Q3 2023 | 2023-03-31 | $724,000 | −$88,000 | −10.84% |
| Q2 2023 | 2022-12-31 | $1.2M | — | — |
| Q1 2023 | 2022-09-30 | $969,000 | $487,000 | +101.04% |
| Q3 2022 | 2022-03-31 | $812,000 | $193,000 | +31.18% |
| Q1 2022 | 2021-09-30 | $482,000 | — | — |
| Q3 2021 | 2021-03-31 | $619,000 | — | — |
Renalytix revenue growth trends
Renalytix's latest reported quarter, Q2 2025, generated $729,000 in revenue, an increase of 2.82% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Renalytix source filings ↗